The Selective GSK3 Inhibitor, SAR502250, Displays Neuroprotective Activity and Attenuates Behavioral Impairments in Models of Neuropsychiatric Symptoms of Alzheimer’s Disease in Rodents

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-54557-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients With Alzheimer’s Disease

Canadian Geriatrics Journal
GerontologyGeriatrics
2013English

Impairments of Attention in Alzheimer’s Disease

Current Opinion in Psychology
Psychology
2019English

Bojungikgi-Tang, a Traditional Herbal Formula, Exerts Neuroprotective Effects and Ameliorates Memory Impairments in Alzheimer’s Disease-Like Experimental Models

Nutrients
NutritionFood ScienceDietetics
2018English

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2019English

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer’s Disease

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2020English

Cholinergic–serotonergic Imbalance Contributes to Cognitive and Behavioral Symptoms in Alzheimer’s Disease

Neuropsychologia
Cognitive NeuroscienceBehavioral NeuroscienceExperimentalCognitive Psychology
2005English

A Strategy for Developing New Treatment Paradigms for Neuropsychiatric and Neurocognitive Symptoms in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2013English

Associations of Cerebrovascular Metabolism Genotypes With Neuropsychiatric Symptoms and Age at Onset of Alzheimer’s Disease Dementia

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2017English

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders
PsychiatryGerontologyGeriatricsMental HealthCognitive Neuroscience
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy